Green Synthesis of Indeno[1,2-b]quinoxalines Using β-Cyclodextrin as Catalyst.

An efficient, mild, and green method was developed for the synthesis of indeno[1,2-b]quinoxaline derivatives via o-phenylenediamine (OPD) and 2-indanone derivatives utilizing β-cyclodextrin (β-CD) as the supramolecular catalyst. The reaction can be carried out in water and in a solid state at room temperature. β-CD can also catalyze the reaction of indan-1,2-dione with OPD with a high degree of efficiency. Compared to the reported methods, this procedure is milder, simpler, and less toxic, making it an eco-friendly alternative. In addition, the β-CD can be recovered and reused without the loss of activity.

1. Introduction

Indeno[1,2-b]quinoxaline skeleton compounds exist in a wide number of drug candidates [1,2,3,4,5,6,7]. They exhibit diverse biological properties, such as acetylcholinesterase (AChE) inhibitory activity (I) [1], antitumor activity (II) [2,3], α-glucosidase inhibition (III) [4], c-Jun N-terminal kinase (JNK) inhibition (IV) [5,6], and tryptophan-tRNA synthase (TrpRS) inhibition (V) [7]. Furthermore, functionally substituted indeno[2,3-b]quinoxalines show potential as acid corrosion inhibitors for mild steel surfaces (VI) [8] and can be used as a photonic sensor to detect fluorescent dyes in the waste effluents of textiles, paper, dyes, and other industrial products (VII) [9] (Figure 1).

Figure 1

Some active compounds of the indeno[1,2-b]quinoxaline skeleton.

Therefore, a great deal of attention has been paid to the construction of indeno[1,2-b]quinoxaline skeleton compounds [10]. Among these methods, the condensation of OPD with indan-1,2-diones or 1,2,3-indanetriones [11,12,13] (Scheme 1, Equation (i)) and the α-halogenation of 1-indanones with OPDs are the most commonly practiced [14,15] (Scheme 1, Equation (ii)). In addition to these strategies, other oxidation methods or ways of using other types of substrates have also been developed, such as the reaction between 2-indanone and OPD [16] (Scheme 1, Equation (iii)). However, most of these methodologies still suffer from some disadvantages, such as the use of toxic or strongly alkaline catalysts, hazardous solvents, a complicated process, or the formation of side products. In recent decades, the increasing awareness of environmental security and global warming has attracted worldwide attention to the use of eco-friendly and atom-economical conditions in organic synthesis [17,18]. Therefore, it is of great use to develop a simple, mild, and environmentally benign methodology for the synthesis of indeno[1,2-b]quinoxaline derivatives.

Scheme 1

Research background and our initial proposal.

Cyclodextrins (CDs) are cyclic oligosaccharides made from starch and generally consist of six, seven, or eight D-(+)-glucose units referred to as α-, β-, and γ-CD, respectively. They possess a truncated cone structure with a hydrophobic cavity and a hydrophilic surface [19]. This unique structure renders CDs with aqueous solubility and the ability to form host–guest inclusion complexes with guest molecules. The selective inclusion process is similar to the behavior of the enzymatic catalytic reaction [20]. Therefore, CDs have attracted much attention as a biomimetic catalyst and have been demonstrated to promote a broad range of chemical reactions in benign, mild conditions [21,22]. For example, Nageswar et al. reported the synthesis of quinoxaline derivatives from OPD and phenacyl bromides in the presence of β-CD in water [23], and Kakulapati et al. reported one-pot synthesis of quinoxalines by OPD with aerobic oxidation of benzoins using Ru/C in Ra-Me-β-CD [24]. However, these two methods still require heating or a Ru/C catalyst to assist with the reaction. In this study, we explored the synthesis of indeno[1,2-b]quinoxalines at room temperature using β-CD as a catalyst (Scheme 1, Equation (iv)). The results showed that β-CD exhibits high catalytic performance for the construction of indeno[1,2-b]quinoxaline skeleton compounds from 2-indanone and OPD under mild conditions in an aqueous medium. In addition, a plausible mechanism was proposed on the basis of two-dimensional nuclear magnetic resonance spectroscopy (2D NMR).

2. Results and Discussion

First, using 2-indanone and OPD as template substrates, we compared the catalytic effects of the base and of different CDs at room temperature (Table 1, entries 2–8) and ascertained whether the reaction could be carried out in the absence of a catalyst (Table 1, entry 1). We found there were trace products in the water without a catalyst, and that the CDs showed better catalytic activity than the base catalyst, triethylamine (Table 1, entry 8). Among the different CDs, β-CD gave 2.3aa in the best yield (Table 1, entries 2–4), which suggested that the size of the cavity of the CDs (α-CD: 5.7 Å cavity, β-CD: 7.8 Å cavity, and γ-CD: 9.5 Å cavity) plays an important role in the catalysis [19] and that β-CD had the optimal cavity size. The catalytic efficiencies of different β-CDs were varied (Table 1, entries 3, 5–7). We found that the substitution markedly decreased the catalytic efficiency of β-CD. When three hydroxyl groups of β-CD were replaced by methyl, the yield decreased from 85% to 38%, suggesting that the hydroxyl groups of β-CD were beneficial to the catalysis.

Table 1

Optimization of reaction conditions in the synthesis of indeno[1,2-b]quinoxaline from 2-indanone and OPD .

Entry	2.2a/2.1a	Cat	Solvent	Temperature (°C)	Time (h)	Yield c (2.3)
1	1.5	No Catalyst	H2O	R.T	24	Trace
2	1.5	α-CD (20 Mol%)	H2O	R.T	24	61
3	1.5	β-CD (20 Mol%)	H2O	R.T	24	85
4	1.5	γ-CD (20 Mol%)	H2O	R.T	24	52
5	1.5	Trimethyl-β-CD (20 Mol%)	H2O	R.T	24	38
6	1.5	2,6-Dimethyl-β-CD (20 Mol%)	H2O	R.T	24	56
7	1.5	Me-β-CD	H2O	R.T	24	53
8	1.5	NEt3 (20 Mol%)	H2O	60	24	33
9	1.5	β-CD (20 Mol%, grind)	None	R.T	0.5	70
10 b	1.5	β-CD (20 Mol%)	H2O	R.T	24	Trace
11	1.5	β-CD (20 Mol%)	DMSO	R.T	24	73
12	1.5	β-CD (20 Mol%)	DMF	R.T	24	76
13	1.5	β-CD (20 Mol%)	EtOH	R.T	24	67
14	1.5	β-CD (20 Mol%)	H2O	60	24	43
15	1.5	β-CD (15 Mol%)	H2O	R.T	12	85
16	1.2	β-CD (15 Mol%)	H2O	R.T	12	85
17	1.0	β-CD (15 Mol%)	H2O	R.T	12	81

Standard reaction conditions: 2.1a (0.2 mmol), 2.2a (1.0–1.5 eq) with various reaction conditions in air. Instead of air in a nitrogen atmosphere. Isolated yields. R.T = room temperature (25 °C).

We also carried out a solvent-free reaction (Table 1, entry 9). We found that there was a 70% yield by grinding substrates for 0.5 h. However, the yield of this solid-state reaction did not improve with increased time, which might indicate insufficient contact between the substrates and the catalyst. One-pot solid-state synthesis is an excellent green technique. Although the yield of indeno[1,2-b]quinoxaline is only moderate, this β-CD-catalyzed solid-state synthesis method is still a potential alterative for the construction of indeno[1,2-b]quinoxaline skeleton compounds. We also carried out the reaction in a nitrogen atmosphere. We found that only trace amounts of the product were produced (Table 1, entry 10), indicating that oxygen is necessary for the reaction.

Choosing β-CD as the catalyst, we screened the reaction solvents: dimethyl sulfoxide (DMSO), N,N-dimethyl formamide (DMF), and ethanol (EtOH) (Table 1, entries 11–13). We found that water gave the best result.

The influence of the reaction time, catalyst dosage, temperature, and substrate dosage on the reaction was also investigated (Table 1, entries 13–17). It can be seen that high temperatures were unfavorable to the reaction. This finding indicated that the inclusion complex between substrates and β-CD is very important for the catalysis, since high temperatures reduce the inclusion complexation. Finally, we found the optimal reaction conditions are as follows: molar ration of 2.2a/2.1a is 1.2: 1, reaction time of 12 h, and concentration of β-CD of 15 mol% (Table 1, entry 16).

After determining the optimal conditions, we extended the process to other substrates. The results are shown in Figure 2. We observed that the substitution groups on OPD decreased the product yield significantly, while the substituents on 2-indanone had relatively little effect on the yield. For example, the product (2.3ad-1 and 2.3ad-2) yield was only 54% when the OPD was substituted in 4-Cl. However, the product (2.3ba-1 and 2.3ba-2) yield was 80% when the chlorine substitution occurred on the benzene ring of 2-indanone. The substitutions of the electron donor groups and of the electron withdrawing groups on the OPD both led to a decrease in product yield. A double substitution caused a greater reduction in the yield than a single substitution. It is interesting that 2,3-diaminonaphthalene reacted with 2-indanone better than the OPD. The yield of the corresponding product (2.3aj) was 89%. It is known that the inclusion constant of naphthalene and β-CD is greater than that of benzene and its derivatives [25,26,27]. Therefore, it is supposed that the complexation of β-CD and OPD and its derivatives played a key role in the catalysis.

Figure 2

Scope of the various substituted 2-indanones (2.1) and o-phenylenediamines (2.2) to synthesis of indeno[1,2-b]quinoxalines (2.3) in optimal conditions.

In order to investigate the mechanism, the complexations of β-CD mixed with three substrates (2-indanone, OPD, and 2,3-diaminonaphthalene) were investigated by 2D NOESY NMR. As shown in Figure 3a, the characteristic peaks of 2-indanone, δ 7.29 and 7.24 (low-field field) and δ 3.53 (the high field), were not related with the peaks of β-CD, indicating that 2-indanone cannot enter the β-CD cavity. On the contrary, the amino characteristic peak of 2.2a at δ 4.35 and the amino characteristic peak of 2.2j at δ 4.94 showed a clear relation with the peak of β-CD (C2-OH and C3-OH) [28] (Figure 3b,c, the blue line). In addition, 2.2a and 2.2j were also related with β-CD near δ 3.30 (see the detailed information in Figures S53 and S54). This suggests that OPD and 2,3-diaminonaphthalene can be included in the β-CD cavity to form the inclusion complex.

Figure 3

The 2D NOESY NMR spectra of freeze-dried: (a) 2-indanone (1.0 eqv.) and β-CD (15 mol%), (b) o-phenylenediamine (1.2 eqv.) and β-CD (15 mol%), and (c) 2,3-diaminonaphthalene (1.2 eqv.) and β-CD (15 mol%). Mixed after stirring in water for 12 h.

Based on the above data and the reports documented in the literature [29,30,31,32], a plausible reaction mechanism is proposed in Scheme 2. First, OPD is included in the cavity of β-CD to form the OPD-β-CD inclusion complex. The reactivity of the amino groups of OPD increases due to the formation of intermolecular hydrogen bonding with the hydroxy groups in β-CD. Then, the first Schiff base reaction takes place, removing a mole of water to form intermediate 3 [31]. The generated intermediate 3 is immediately oxidized by oxygen in the air to form the intermediate 4, leading to the second Schiff base reaction [32]. The presence of intermediates 3 and 4 was confirmed by high-resolution mass spectrometry (HRMS). We found that there were clear intermediate peaks for 3 and 4 in the HRMS spectrum of the reaction solution after a one-hour reaction (Figure S55). Previous studies reported that a base was needed for the monocarbonylated compounds oxidation during quinoxaline synthesis [30]. It is interesting that a high yield was still obtained by using β-CD as a catalyst in the absence of a base in this study. Ji et al. reported that β-CD could improve the synthesis of 2-phenylbezimidazole using air as an oxidant, since the oxidative cyclodehydrogenation of the Schiff base intermediates was promoted inside the β-CD cavity [29]. Therefore, it is supposed that the mechanism of β-CD catalysis in this study is also due to the promotion of oxidative cyclodehydrogenation. Finally, the β-CD catalyst returns to its initial state by releasing the product from its cavity.

Scheme 2

A plausible mechanism for the reaction.

After the completion of the reaction, the β-CD can be recycled after the extraction of the products by using ethyl acetate. The reusability of the catalyst was examined four times for the synthesis of 2.3aa, and there was no significant reduction in the yield (Figure 4).

Figure 4

Recyclability of the catalyst.

β-CD can also catalyze the reaction of indan-1,2-dione with OPD (Scheme 3). Previous research on the reaction of indan-1,2-dione with OPD used ammonium bifluoride as a catalyst and methanol–water as a solvent [11]. The strategy developed in this study is not only more environmentally friendly, but also more efficient.

Scheme 3

The application of cyclodextrin biomimetic catalysis.

3. Materials and Methods

3.1. General

Commercial reagents were purchased from Sigma-Aldrich, Aladdin Reagent Database Inc. and Bide pharmatech Ltd. (without further purification). 1H, 13C NMR, and NOESY spectra were recorded on a Bruker AVANCE 600 instrument using DMSO-d6 or CDCl3 as a solvent. Chemical shifts δ are expressed in parts per million (ppm) and internally referenced to tetramethylsilane (TMS). The coupling constant J is reported in Hz. The following abbreviations are used: s = singlet, d = doublet, t = triplet, q = quartet, and m = multiplet. High-resolution mass spectra (HRMS) were obtained on a micrOTOF-QII mass spectrometer (Bruker, Germany) or a Vion® IMS QTof mass spectrometer (Waters, UK). The ionization method chosen was electrospray ionization (ESI) operated in positive ion mode. All the reaction procedures were monitored by TLC using 40 precoated sheets of silica gel G/UV-254 of 0.25 mm thickness, Merck 60 F254 (BioLong, China). TLC plates were visualized by exposure to ultraviolet light and/or by exposure to iodine vapors, and the product was obtained by chromatography performed on silica gel (200–300 mesh).

3.2. General Procedure for the Synthesis of Compounds 2.3(aa-bb)

2-indanone (0.1 mmol, 26.4 mg), OPD (0.1 mmol, 26.0 mg), and β-CD (15 mol%, 34.1 mg) were mixed in distilled water (2.5 mL). The reaction mixture was stirred at room temperature (25.0 °C) for 12 h. After the completion of the reaction, the reaction mixture was extracted with ethyl acetate. Then, the organic layer was dried through Na2SO4 and concentrated in vacuo. Finally, the crude product was purified by flash chromatography on a short silica gel (eluent: petroleum ether/ethyl acetate =10:1) to afford 37.1 mg (85%) of 2.3aa. Other product compounds 2.3(ab-bb) were synthesized by similar methods.

11H-indeno[1,2-b]quinoxaline (2.3aa)

Yellow solid; 85% yield; 1H NMR (600 MHz, CDCl3) δ: 8.34–8.26 (m, 1H), 8.21 (dd, J = 8.0, 1.7 Hz, 1H), 8.11 (dd, J = 8.0, 1.7 Hz, 1H), 7.75 (dddd, J = 18.0, 8.3, 6.9, 1.6 Hz, 2H), 7.68 (dt, J = 7.3, 1.2 Hz, 1H), 7.60–7.52 (m, 2H), 4.17 (s, 2H); 13C NMR (100 MHz, CDCl3) δ: 159.48, 154.67, 143.52, 142.07, 141.26, 138.04, 131.15, 129.26, 129.21, 128.97, 128.84, 128.06, 125.83, 122.70, 35.98; HRMS (ESI) calcd for C15H11N2+ (M+H)+ 219.0917, found 219.0912.

7/8-methyl-11H-indeno[1,2-b]quinoxaline (2.3ab-1 and 2.3ab-2)

2.3ab-1 and 2.3ab-2 cannot be separated through column chromatography; yellow solid; 81% yield; 1H NMR (600 MHz, CDCl3) δ: 8.23–8.15 (m, 1H), 7.97 (dd, J = 46.4, 8.4 Hz, 1H), 7.85 (dd, J = 51.9, 1.8 Hz, 1H), 7.59 (dddd, J = 5.0, 3.2, 2.0, 1.0 Hz, 1H), 7.55–7.44 (m, 3H), 4.06 (s, 2H), 2.57 (s, 3H); 13C NMR (150 MHz, CDCl3) δ 159.29, 158.43, 154.41, 153.76, 143.44, 143.21, 142.02, 141.26, 140.35, 139.63, 139.53, 139.19, 138.17, 131.29, 130.89, 130.84, 130.71, 128.67, 128.40, 128.23, 128.00, 127.89, 125.68, 122.53, 122.39, 77.25, 77.04, 76.83, 35.93, 35.84, 21.73, 21.70; HRMS (ESI) calcd for C16H13N2+ (M + H)+ 233.1073, found 233.1068.

7-methoxy-11H-indeno[1,2-b]quinoxaline (2.3ac-1)

White solid; 41% yield; 1H NMR (600 MHz, CDCl3) δ: 8.27 (d, J = 6.9 Hz, 1H), 7.99 (d, J = 9.1 Hz, 1H), 7.67 (d, J = 6.8 Hz, 1H), 7.58–7.50 (m, 3H), 7.38 (dd, J = 9.1, 2.8 Hz, 1H), 4.13 (s, 2H), 4.00 (s, 3H); 13C NMR (150 MHz, CDCl3) δ: 160.41, 156.90, 143.69, 138.13, 137.25, 130.94, 129.80, 127.99, 125.81, 122.54, 121.59, 107.13, 77.20, 76.99, 76.78, 55.81, 35.81; HRMS (ESI) calcd for C16H13N2O+ (M + H)+ 249.1022, found 249.1023.

8-methoxy-11H-indeno[1,2-b]quinoxaline (2.3ac-2)

White solid; 26% yield; 1H NMR (600 MHz, CDCl3) δ: 8.22 (dd, J = 5.3, 3.5 Hz, 1H), 8.07 (d, J = 9.1 Hz, 1H), 7.69–7.61 (m, 1H), 7.53 (dd, J = 5.6, 3.1 Hz, 2H), 7.44 (d, J = 2.8 Hz, 1H), 7.41 (dd, J = 9.1, 2.8 Hz, 1H), 4.13 (s, 2H), 3.99 (s, 3H); 13C NMR (150 MHz, CDCl3) δ: 160.10, 159.58, 152.53, 142.78, 142.74, 138.39, 137.85, 130.44, 130.08, 127.95, 125.70, 122.12, 121.82, 107.24, 77.21, 76.99, 76.78, 55.74, 36.00; HRMS (ESI) calcd for C16H13N2O+ (M + H)+ 249.1022, found 249.1027.

7-chloro-11H-indeno[1,2-b]quinoxaline (2.3ad-1)

Yellow solid; 31% yield; 1H NMR (600 MHz, CDCl3) δ 8.24 (d, J = 7.6 Hz, 1H), 8.15 (d, J = 2.3 Hz, 1H), 8.01 (d, J = 8.8 Hz, 1H), 7.65 (td, J = 7.1, 6.7, 3.1 Hz, 2H), 7.59–7.50 (m, 2H), 4.12 (s, 2H); 13C NMR (150 MHz, CDCl3) δ 159.70, 155.26, 143.74, 142.28, 139.71, 137.54, 134.97, 131.61, 130.06, 129.63, 128.19, 128.08, 125.84, 123.03, 35.91; HRMS (ESI) calcd for C15H10ClN2+ (M + H)+ 253.0527, found 253.0517.

8-chloro-11H-indeno[1,2-b]quinoxaline (2.3ad-2)

White solid; 23% yield; 1H NMR (600 MHz, CDCl3) δ 8.22–8.16 (m, 1H), 8.09–8.00 (m, 2H), 7.69–7.60 (m, 2H), 7.58–7.46 (m, 2H), 4.10 (s, 2H); 13C NMR (150 MHz, CDCl3) δ 160.43, 154.81, 143.45, 141.50, 140.56, 137.67, 134.32, 131.37, 130.28, 130.07, 128.13, 128.00, 125.81, 122.72, 35.93; HRMS (ESI) calcd for C15H10ClN2+ (M + H)+ 253.0527, found 253.0520.

7-bromo-11H-indeno[1,2-b]quinoxaline (2.3ae-1)

Yellow solid; 38% yield; 1H NMR (600 MHz, CDCl3) δ: 8.33 (d, J = 2.1 Hz, 1H), 8.22 (d, J = 7.4 Hz, 1H), 7.94 (d, J = 8.8 Hz, 1H), 7.77 (dd, J = 8.8, 2.2 Hz, 1H), 7.65 (d, J = 7.4 Hz, 1H), 7.58–7.52 (m, 2H), 4.11 (s, 2H); 13C NMR (150 MHz, CDCl3) δ: 159.81, 155.32, 143.70, 142.78, 140.00, 137.65, 132.14, 131.53, 130.21, 128.17, 125.82, 122.97, 122.92, 35.94; HRMS (ESI) calcd for C15H10BrN2+ (M + H)+ 297.0022, found 297.0027.

8-bromo-11H-indeno[1,2-b]quinoxaline (2.3ae-2)

Yellow solid; 22% yield; 1H NMR (600 MHz, CDCl3) δ: 8.30–8.20 (m, 2H), 8.01 (d, J = 8.8 Hz, 1H), 7.81 (dd, J = 8.9, 2.2 Hz, 1H), 7.70–7.63 (m, 1H), 7.60–7.49 (m, 2H), 4.13 (s, 2H); 13C NMR (150 MHz, CDCl3) δ: 160.40, 154.93, 143.54, 141.85, 140.88, 137.71, 132.66, 131.42, 131.36, 130.44, 128.16, 125.84, 122.78, 122.41, 35.96; HRMS (ESI) calcd for C15H10BrN2+ (M + H)+ 297.0022, found 297.0024.

7,8-dimethyl-11H-indeno[1,2-b]quinoxaline (2.3af)

Pale yellow solid; 73% yield; 1H NMR (600 MHz, CDCl3) δ: 8.31–8.15 (m, 1H), 7.92 (s, 1H), 7.83 (s, 1H), 7.64 (ddd, J = 5.4, 2.7, 1.0 Hz, 1H), 7.55–7.48 (m, 2H), 4.11 (s, 2H), 2.50 (t, J = 1.2 Hz, 6H); 13C NMR (150 MHz, CDCl3) δ: 158.46, 153.73, 143.26, 140.82, 140.15, 139.47, 139.16, 138.40, 130.62, 128.44, 128.21, 127.90, 125.71, 122.36, 35.94, 20.29, 20.25; HRMS (ESI) calcd for C17H15N2+ (M + H)+ 247.1230, found 247.1229.

7,8-difluoro-11H-indeno[1,2-b]quinoxaline (2.3ag)

Yellow solid; 43% yield; 1H NMR (600 MHz, CDCl3) δ: 8.22 (d, J = 7.3 Hz, 1H), 7.91 (dd, J = 10.7, 8.2 Hz, 1H), 7.84 (dd, J = 10.6, 8.1 Hz, 1H), 7.70–7.65 (m, 1H), 7.60–7.53 (m, 2H), 4.14 (s, 2H); 13C NMR (150 MHz, CDCl3) δ: 159.81, 154.93, 143.35, 139.29, 138.30, 138.23, 137.62, 131.47, 128.19, 125.84, 122.75, 115.04, 114.94, 114.83, 35.88; HRMS (ESI) calcd for C15H9F2N2+ (M + H)+ 255.0728, found 255.0735.

7,8-dichloro-11H-indeno[1,2-b]quinoxaline (2.3ah)

Yellow solid; 50% yield; 1H NMR (600 MHz, CDCl3) δ: 8.29 (s, 1H), 8.24 (d, J = 7.5 Hz, 1H), 8.21 (s, 1H), 7.68 (d, J = 7.4 Hz, 1H), 7.62–7.53 (m, 2H), 4.15 (s, 2H); 13C NMR (150 MHz, CDCl3) δ: 160.70, 155.61, 143.68, 140.95, 139.99, 137.45, 133.58, 132.96, 131.78, 129.82, 129.66, 128.27, 125.88, 123.00, 77.20, 76.99, 76.78, 35.95; HRMS (ESI) calcd for C15H9Cl2N2+ (M + H)+ 287.0137, found 287.0145.7,8-dibromo-11H-indeno[1,2-b]quinoxaline (2.3ai).

Yellow solid; 46% yield; 1H NMR (600 MHz, CDCl3) δ: 8.48 (s, 1H), 8.40 (s, 1H), 8.23 (d, J = 7.5 Hz, 1H), 7.68 (d, J = 7.5 Hz, 1H), 7.62–7.53 (m, 2H), 4.14 (s, 2H); 13C NMR (150 MHz, CDCl3) δ: 160.80, 155.66, 143.76, 141.47, 140.51, 137.44, 133.23, 133.05, 131.83, 128.29, 125.89, 125.54, 124.87, 123.04, 35.98; HRMS (ESI) calcd for C15H9Br2N2+ (M + H)+ 374.9127, found 374.9125.

13H-benzo[g]indeno[1,2-b]quinoxaline (2.3aj)

Yellow solid; 89% yield; 1H NMR (600 MHz, CDCl3) δ: 8.71 (s, 1H), 8.62 (s, 1H), 8.30 (dd, J = 7.3, 1.5 Hz, 1H), 8.13–8.08 (m, 2H), 7.66 (dt, J = 7.6, 1.1 Hz, 1H), 7.60–7.53 (m, 4H), 4.18 (s, 2H); 13C NMR (150 MHz, CDCl3) δ 160.36, 155.22, 143.93, 138.82, 138.16, 137.88, 133.52, 133.20, 131.72, 128.34, 128.30, 128.17, 127.35, 127.08, 126.50, 126.41, 125.91, 123.06, 35.95; HRMS (ESI) calcd for C19H13N2+ (M + H)+ 269.1073, found 269.1067.

2-chloro-11H-indeno[1,2-b]quinoxaline (2.3ba-1)

White solid; 42% yield; 1H NMR (600 MHz, CDCl3) δ: 8.21–8.13 (m, 2H), 8.10 (dd, J = 8.0, 1.8 Hz, 1H), 7.80–7.70 (m, 2H), 7.66 (d, J = 1.8 Hz, 1H), 7.52 (dd, J = 8.2, 1.8 Hz, 1H), 4.14 (s, 2H); 13C NMR (150 MHz, CDCl3) δ: 158.89, 153.60, 144.93, 142.07, 141.27, 137.16, 136.61, 129.46, 129.21, 129.08, 129.01, 128.67, 126.17, 123.71, 77.21, 77.00, 76.79, 35.80; HRMS (ESI) calcd for C15H10ClN2+ (M + H)+ 253.0527, found 253.0517.

3-chloro-11H-indeno[1,2-b]quinoxaline (2.3ba-2)

White solid; 38% yield; 1H NMR (600 MHz, CDCl3) δ: 8.22 (d, J = 2.0 Hz, 1H), 8.17–8.15 (m, 1H), 8.09 (dd, J = 7.9, 1.8 Hz, 1H), 7.78–7.72 (m, 2H), 7.58 (d, J = 8.1 Hz, 1H), 7.50 (dd, J = 8.1, 2.1 Hz, 1H), 4.11 (s, 2H); 13C NMR (150 MHz, CDCl3) δ: 159.28, 153.47, 142.06, 141.52, 141.47, 139.71, 134.32, 131.04, 129.47, 129.34, 129.25, 129.00, 126.92, 122.71, 35.60; HRMS (ESI) calcd for C15H10ClN2+ (M + H)+ 253.0527, found 253.0519.

2-chloro-7,8-dimethyl-11H-indeno[1,2-b]quinoxaline (2.3bb-1)

White solid; 36% yield; 1H NMR (600 MHz, CDCl3) δ: 8.16 (d, J = 2.0 Hz, 1H), 7.88 (s, 1H), 7.80 (s, 1H), 7.54 (d, J = 8.0 Hz, 1H), 7.45 (dd, J = 8.1, 2.0 Hz, 1H), 4.04 (s, 2H), 2.49 (d, J = 3.0 Hz, 6H); 13C NMR (150 MHz, CDCl3) δ: 158.27, 152.50, 141.25, 140.82, 140.33, 140.06, 139.79, 139.71, 134.12, 130.47, 128.48, 128.17, 126.78, 122.35, 35.54, 20.32, 20.27; HRMS (ESI) calcd for C17H14ClN2+ (M + H)+ 281.0840, found 281.0833.

3-chloro-7,8-dimethyl-11H-indeno[1,2-b]quinoxaline (2.3bb-2)

White solid; 40% yield; 1H NMR (600 MHz, Chloroform-d) δ: 8.10 (d, J = 8.1 Hz, 1H), 7.87 (s, 1H), 7.79 (s, 1H), 7.59 (d, J = 1.8 Hz, 1H), 7.46 (dd, J = 8.1, 1.9 Hz, 1H), 4.05 (s, 2H), 2.49 (s, 6H); 13C NMR (150 MHz, CDCl3) δ: 157.83, 152.59, 144.64, 140.76, 140.09, 139.73, 139.48, 136.88, 136.53, 128.43, 128.37, 128.19, 125.99, 123.30, 35.73, 20.30, 20.26; HRMS (ESI) calcd for C17H14ClN2+ (M + H)+ 281.0840, found 281.0834.

3.3. Recycle of β-CD after Synthesis

After completion of the reaction, the mixture was extracted by ethyl acetate (2 × 10 mL) and dried over anhydrous sodium sulfate. Ethyl acetate was removed in a vacuum and the crude product was obtained. Then, the water layer was recycled and removed in a vacuum to obtain the reused catalyst.

4. Conclusions

In conclusion, we developed a simple one-pot method for the synthesis of indeno[1,2-b]quinoxaline derivatives from the reaction of 2-indanones with OPDs using β-CD as a catalyst in water. This method has the advantages of high-yield, low-cost, biomimetic, and neutral aqueous-phase conditions. It is environmentally friendly; moreover, the catalyst is easy to recover and to reuse. Therefore, this straightforward method may find widespread applications in medicinal and organic chemistry.